NCT00003330View on ClinicalTrials.gov

Interleukin-12 in Treating Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

July 31, 1998

Primary Completion Date

April 30, 2002

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

recombinant interleukin-12

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00003330 - Interleukin-12 in Treating Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter